It is found that Retatrutide, an anti‐obesity agent, inhibits HBP and YAP O‐GlcNAcylation leading to increased YAP degradation through the deprivation of EIF3H‐mediated deubiquitylation of YAP. Here, EIF3H is linked to Obesity.